Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapeutic angiogenesis: a biologic bypass.

Imran S Syed1, Timothy A Sanborn, Todd K Rosengart

  • 1Evanston Northwestern Healthcare, Evanston, IL, USA.

Cardiology
|February 28, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Warm ischemic time-dependent effects on oxidative stress, endoplasmic reticulum stress, and inflammation in cold storage human donor hearts.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Administration of a novel reprogramming formula improves cardiac function and decreases cardiac fibrosis in a myocardial infarction model.

JTCVS open·2025
Same author

The state of educational research in cardiothoracic surgery: A review of the literature.

JTCVS open·2025
Same author

Brain death versus circulatory death: how functional warm ischemia and cold storage impact myocardial membrane repair in human donor hearts.

American journal of physiology. Heart and circulatory physiology·2025
Same author

Effect of cold storage solution on warm ischemia-induced myocardial plasma membrane damage and pyroptosis in human hearts from circulatory death donors.

The Journal of thoracic and cardiovascular surgery·2025
Same author

Tissue perfusion pressure: A novel hemodynamic measure to assess risk of acute kidney injury after cardiac surgery.

The Journal of thoracic and cardiovascular surgery·2025

Therapeutic angiogenesis using angiogenic factors offers a promising treatment for diffuse coronary artery disease. Early trials show reduced angina and improved heart function, providing hope for non-traditional revascularization candidates.

Area of Science:

  • Cardiovascular Medicine
  • Regenerative Medicine
  • Molecular Biology

Background:

  • Diffuse coronary artery disease (CAD) affects many patients unsuitable for traditional revascularization.
  • Therapeutic angiogenesis aims to stimulate new blood vessel growth to improve blood flow.
  • Angiogenic factors are key targets for promoting this new vessel formation.

Purpose of the Study:

  • To evaluate the potential of using angiogenic factors for therapeutic angiogenesis in patients with diffuse coronary artery disease.
  • To assess the efficacy and safety of protein or gene-based delivery of angiogenic factors.
  • To review early clinical trial outcomes for therapeutic angiogenesis treatments.

Main Methods:

  • Delivery of angiogenic factors via protein or gene-based approaches.

Related Experiment Videos

  • Preclinical studies in animal models to demonstrate angiogenesis induction.
  • Clinical trials assessing patient outcomes and objective measures of cardiac function.

    • Main Results:

    • Successful induction of angiogenesis demonstrated in multiple animal models.
    • Expression and function of delivered angiogenic factors confirmed.
    • Early clinical trials reported reduced anginal symptoms and increased exercise tolerance.
    • Objective improvements observed in myocardial perfusion, left ventricular function, and coronary angiographic appearance.

    Conclusions:

    • Therapeutic angiogenesis using angiogenic factors is a viable treatment option for diffuse coronary artery disease.
    • Protein and gene delivery methods have shown promise in preclinical and early clinical studies.
    • Further research and clinical trials are warranted to optimize this treatment modality.